230 related articles for article (PubMed ID: 19131553)
1. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.
Pise-Masison CA; Radonovich M; Dohoney K; Morris JC; O'Mahony D; Lee MJ; Trepel J; Waldmann TA; Janik JE; Brady JN
Blood; 2009 Apr; 113(17):4016-26. PubMed ID: 19131553
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines.
Che XF; Zheng CL; Owatari S; Mutoh M; Gotanda T; Jeung HC; Furukawa T; Ikeda R; Yamamoto M; Haraguchi M; Arima N; Akiyama S
Blood; 2006 Jun; 107(12):4880-7. PubMed ID: 16497974
[TBL] [Abstract][Full Text] [Related]
3. Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia.
Chen J; Pise-Masison CA; Shih JH; Morris JC; Janik JE; Conlon KC; Keating A; Waldmann TA
Blood; 2013 Mar; 121(11):2029-37. PubMed ID: 23321252
[TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Berkowitz JL; Janik JE; Stewart DM; Jaffe ES; Stetler-Stevenson M; Shih JH; Fleisher TA; Turner M; Urquhart NE; Wharfe GH; Figg WD; Peer CJ; Goldman CK; Waldmann TA; Morris JC
Clin Immunol; 2014 Dec; 155(2):176-87. PubMed ID: 25267440
[TBL] [Abstract][Full Text] [Related]
5. Promise of combining a Bcl-2 family inhibitor with bortezomib or SAHA for adult T-cell leukemia/lymphoma.
Kunami N; Katsuya H; Nogami R; Ishitsuka K; Tamura K
Anticancer Res; 2014 Oct; 34(10):5287-94. PubMed ID: 25275021
[TBL] [Abstract][Full Text] [Related]
6. Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?
Subramanian K; Dierckx T; Khouri R; Menezes SM; Kagdi H; Taylor GP; Farre L; Bittencourt A; Kataoka K; Ogawa S; Van Weyenbergh J
Int J Cancer; 2019 Apr; 144(7):1664-1675. PubMed ID: 30303535
[TBL] [Abstract][Full Text] [Related]
7. Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model.
Yu P; Petrus MN; Ju W; Zhang M; Conlon KC; Nakagawa M; Maeda M; Bamford RN; Waldmann TA
Leukemia; 2015 Mar; 29(3):556-66. PubMed ID: 25118879
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.
Chen J; Zhang M; Ju W; Waldmann TA
Blood; 2009 Feb; 113(6):1287-93. PubMed ID: 18948574
[TBL] [Abstract][Full Text] [Related]
9. Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.
Gazon H; Belrose G; Terol M; Meniane JC; Mesnard JM; Césaire R; Peloponese JM
Oncotarget; 2016 May; 7(21):30258-75. PubMed ID: 26849145
[TBL] [Abstract][Full Text] [Related]
10. Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells.
Nagai K; Jinnai I; Hata T; Usui T; Sasaki D; Tsukasaki K; Sugahara K; Hishikawa Y; Yamada Y; Tanaka Y; Koji T; Mano H; Kamihira S; Tomonaga M
Int J Hematol; 2008 Dec; 88(5):551-564. PubMed ID: 19043810
[TBL] [Abstract][Full Text] [Related]
11. Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma.
El Hajj H; Khalil B; Ghandour B; Nasr R; Shahine S; Ghantous A; Abdel-Samad R; Sinjab A; Hasegawa H; Jabbour M; Hall WW; Zaatari G; Dbaibo G; Pisano C; Bazarbachi A; Darwiche N
Blood; 2014 Sep; 124(13):2072-80. PubMed ID: 25035162
[TBL] [Abstract][Full Text] [Related]
12. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.
Wong RWJ; Ngoc PCT; Leong WZ; Yam AWY; Zhang T; Asamitsu K; Iida S; Okamoto T; Ueda R; Gray NS; Ishida T; Sanda T
Blood; 2017 Nov; 130(21):2326-2338. PubMed ID: 28978570
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes associated with the progression of adult T cell leukemia (ATL).
Kohno T; Moriuchi R; Katamine S; Yamada Y; Tomonaga M; Matsuyama T
Jpn J Cancer Res; 2000 Nov; 91(11):1103-10. PubMed ID: 11092974
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.
Satou Y; Nosaka K; Koya Y; Yasunaga JI; Toyokuni S; Matsuoka M
Leukemia; 2004 Aug; 18(8):1357-63. PubMed ID: 15190257
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2.
Song Z; Wu W; Chen M; Cheng W; Yu J; Fang J; Xu L; Yasunaga JI; Matsuoka M; Zhao T
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258009
[TBL] [Abstract][Full Text] [Related]
16. Repression of IRF-4 target genes in human T cell leukemia virus-1 infection.
Mamane Y; Grandvaux N; Hernandez E; Sharma S; Innocente SA; Lee JM; Azimi N; Lin R; Hiscott J
Oncogene; 2002 Oct; 21(44):6751-65. PubMed ID: 12360402
[TBL] [Abstract][Full Text] [Related]
17. A Tcf4-GFP reporter mouse model for monitoring effects of Apc mutations during intestinal tumorigenesis.
Boman B; Kopelovich L; Siracusa LD; Zhang T; Henderson K; Cofer Z; Buchberg AM; Fields JZ; Otevrel T
Mol Carcinog; 2009 Sep; 48(9):821-31. PubMed ID: 19263440
[TBL] [Abstract][Full Text] [Related]
18. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
19. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.
Nosaka K; Matsuoka M
Cancer Sci; 2021 May; 112(5):1688-1694. PubMed ID: 33630351
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.
Sugahara K; Uemura A; Harasawa H; Nagai H; Hirakata Y; Tomonaga M; Murata K; Sohda H; Nakagoe T; Shibasaki S; Yamada Y; Kamihira S
Int J Hematol; 2004 Jul; 80(1):52-8. PubMed ID: 15293568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
